Continuing effectiveness of serogroup a meningococcal conjugate vaccine, Chad, 2013

Authors :: Gamougam, Kadidja
Daugla, Doumagoum M.
Toralta, Jacques
Ngadoua, Cyriaque
Fermon, Florence
Page, Anne-Laure
Djingarey, Mamoudou H.
Caugant, Dominique A.
Manigart, Olivier
Trotter, Caroline L.
Stuart, James M.
Greenwood, Brian M.
Source :: Emerging Infectious Diseases. January 1, 2015, p115, 4 p.
Publication Year :: 2015
Abstract: For >100 years, countries in the meningitis belt of Africa have experienced intermittent epidemics of meningococcal meningitis, caused mainly by the serogroup A meningococcus (1). After development and prequalification of [...]

Subjects :: Meningitis -- Prevention
Conjugate vaccines -- Patient outcomes
Epidemics -- Prevention -- Chad
Health

Full Text Access

Tools